Skip to main content
SpringerLink
Log in

Preventing Infections and Healthy Aging

  • Chapter
  • First Online:
Healthy Aging

Abstract

Dysregulated immune function in older adults is a hallmark of aging and affects the ability of this vulnerable population to resist infection and respond to vaccination. Pneumonia and influenza are the leading causes of hospitalization and death from infectious disease, and lower respiratory tract infections are the third leading cause of death worldwide (WHO, Media centre fact sheets. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/index.html. Accessed 18 Mar 2018). The decline in immune function with aging is now recognized as being more than immunosenescence. Inflammatory processes associated with the immune response are critical to protection against severe infections, but tissue damage occurs when this response becomes chronic. As we grow older, our ability to regulate this response declines, which leads to the accumulation of high levels of inflammatory mediators circulating in the blood and ongoing tissue damage – this process defines “inflammaging” and appears to be fundamentally implicated in the accelerated progression of chronic diseases, functional decline, and loss of resilience with aging. This chapter will focus on vaccine preventable disability and the current recommendations for vaccination in the population age 50 and older who bear the greatest burden of multiple chronic conditions. Primary, secondary, and tertiary prevention strategies to address the challenges of pneumonia and influenza and herpes zoster start with vaccination and the basics of healthy diets, exercise, and smoking cessation in an aging population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition--multimorbidity. JAMA. 2012;307:2493–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Schellevis FG. Epidemiology of multiple chronic conditions: an international perspective. J Comorb. 2013;3:36–40.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm--issues and controversies. J Gerontol. 2007;62:731–7.

    Article  Google Scholar 

  4. Strandberg TE, Pitkala KH. Frailty in elderly people. Lancet. 2007;369:1328–9.

    Article  PubMed  Google Scholar 

  5. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55:780–91.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bauer JM, De Castro A, Bosco N, et al. Influenza vaccine response in community-dwelling German prefrail and frail individuals. Immun Ageing. 2017;14:17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Zhang HT, McGrath LJ, Wyss R, Ellis AR, Sturmer T. Controlling confounding by frailty when estimating influenza vaccine effectiveness using predictors of dependency in activities of daily living. Pharmacoepidemiol Drug Saf. 2017;26:1500–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Moehling KK, Nowalk MP, Lin CJ, et al. The effect of frailty on HAI response to influenza vaccine among community-dwelling adults >/= 50 years of age. Hum Vaccin Immunother. 2018;14(2):361–7.

    Google Scholar 

  9. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol. 2004;59:255–63.

    Article  Google Scholar 

  10. Stretton CM, Latham NK, Carter KN, Lee AC, Anderson CS. Determinants of physical health in frail older people: the importance of self-efficacy. Clin Rehabil. 2006;20:357–66.

    Article  PubMed  Google Scholar 

  11. Rockwood K, Rockwood MR, Mitnitski A. Physiological redundancy in older adults in relation to the change with age in the slope of a frailty index. J Am Geriatr Soc. 2010;58:318–23.

    Article  PubMed  Google Scholar 

  12. Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58:681–7.

    Article  PubMed  Google Scholar 

  13. Andrew MK, Keefe JM. Social vulnerability from a social ecology perspective: a cohort study of older adults from the National Population Health Survey of Canada. BMC Geriatr. 2014;14:90.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Andrew MK, Mitnitski AB, Rockwood K. Social vulnerability, frailty and mortality in elderly people. PLoS One. 2008;3:e2232.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Andrew MK, Mitnitski A, Kirkland SA, Rockwood K. The impact of social vulnerability on the survival of the fittest older adults. Age Ageing. 2012;41:161–5.

    Article  PubMed  Google Scholar 

  16. Prior A, Fenger-Gron M, Larsen KK, et al. The association between perceived stress and mortality among people with multimorbidity: a prospective population-based cohort study. Am J Epidemiol. 2016;184:199–210.

    Article  PubMed  Google Scholar 

  17. Covinsky KE, Palmer RM, Fortinsky RH, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003;51:451–8.

    Article  PubMed  Google Scholar 

  18. Andrew MK, MacDonald S, Ye L, et al. Impact of frailty on influenza vaccine effectiveness and clinical outcomes: experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season Canadian Immunization Conference. Ottawa, 2016.

    Google Scholar 

  19. McElhaney JE, Andrew MK, McNeil SA. Estimating influenza vaccine effectiveness: evolution of methods to better understand effects of confounding in older adults. Vaccine. 2017;35:6269–74.

    Article  PubMed  Google Scholar 

  20. Franceschi C, Olivieri F, Marchegiani F, et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev. 2005;126:351–61.

    Article  CAS  PubMed  Google Scholar 

  21. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105.

    Article  CAS  PubMed  Google Scholar 

  22. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006;43:1143–51.

    Article  PubMed  Google Scholar 

  23. Derhovanessian E, Larbi A, Pawelec G. Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol. 2009;21:440–5.

    Article  CAS  PubMed  Google Scholar 

  24. Moro-Garcia MA, Alonso-Arias R, Lopez-Vazquez A, et al. Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age (Dordrecht, Netherlands). 2012;34:479–95.

    Article  CAS  Google Scholar 

  25. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959–1999. Am J Epidemiol. 2004;160:492–502.

    Article  PubMed  Google Scholar 

  26. Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 2011;8:e1001048.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86.

    Article  PubMed  Google Scholar 

  28. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499–505.

    Article  CAS  PubMed  Google Scholar 

  29. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–40.

    Article  CAS  PubMed  Google Scholar 

  30. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749–59.

    Article  CAS  PubMed  Google Scholar 

  31. Muller EA. Influence of training and of activity on muscle strength. Arch Phys Med Rehabil. 1970;51:449–62.

    CAS  PubMed  Google Scholar 

  32. Harper CM, Lyles YM. Physiology and complications of bed rest. J Am Geriatr Soc. 1988;36:1047–54.

    Article  CAS  PubMed  Google Scholar 

  33. Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297:1772–4.

    Article  CAS  PubMed  Google Scholar 

  34. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778–84.

    Article  CAS  PubMed  Google Scholar 

  35. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322–32.

    Article  PubMed  Google Scholar 

  36. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–9.

    Article  PubMed  Google Scholar 

  37. Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA. 1997;277:728–34.

    Article  CAS  PubMed  Google Scholar 

  38. World Health Organization. Influenza (seasonal) fact sheet. Available at: http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 9 Aug 2018.

  39. Centers for Disease Control Weekly U.S. Influenza Surveillance Report (FluView), 2017.

    Google Scholar 

  40. Control CfD. Flu Surv-Net. Available at: https://www.cdc.gov/flu/weekly/weeklyarchives2017-2018/EIPrates49.html.

  41. Skowronski DM, Hottes TS, McElhaney JE, et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis. 2011;203:158–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Skowronski DM, Chambers C, Sabaiduc S, et al. Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013–2014 epidemic in Canada. J Infect Dis. 2015;211:109–14.

    Article  PubMed  Google Scholar 

  43. Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM. Immune response to influenza vaccination in a large healthy elderly population. Vaccine. 1999;17:82–94.

    Article  CAS  PubMed  Google Scholar 

  44. Gardner EM, Bernstein ED, Dran S, et al. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine. 2001;19:4610–7.

    Article  CAS  PubMed  Google Scholar 

  45. Murasko DM, Bernstein ED, Gardner EM, et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol. 2002;37:427–39.

    Article  CAS  PubMed  Google Scholar 

  46. Effros RB. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine. 2007;25:599–604.

    Article  CAS  PubMed  Google Scholar 

  47. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol. 2009;21:418–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. McElhaney JE. Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response. Expert Rev Vaccines. 2009;8:593–606.

    Article  PubMed  Google Scholar 

  49. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–45.

    Article  PubMed  Google Scholar 

  50. Merani S, Kuchel GA, Kleppinger A, McElhaney JE. Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage. Exp Gerontol. 2018;107:116–25.

    Google Scholar 

  51. Gravenstein S, Davidson HE, Taljaard M, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Lancet Respir Med. 2017;5:738–46.

    Article  PubMed  Google Scholar 

  52. Raviotta JM, Smith KJ, DePasse J, et al. Cost-effectiveness and public health effect of influenza vaccine strategies for U.S. elderly adults. J Am Geriatr Soc. 2016;64:2126–31.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Mullooly JP, Bridges CB, Thompson WW, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2007;25:846–55.

    Article  PubMed  Google Scholar 

  54. Falsey AR, McElhaney JE, Beran J, et al. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014;209:1873–81.

    Article  PubMed  Google Scholar 

  55. Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc. 1992;40:115–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. WHO. Media centre fact sheets. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/index.html. Accessed 18 Mar 2018.

  57. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012;125:773–81.

    Article  PubMed  Google Scholar 

  58. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.

    Article  PubMed  Google Scholar 

  59. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67:71–9.

    Article  CAS  PubMed  Google Scholar 

  60. Lode HM. Managing community-acquired pneumonia: a European perspective. Respir Med. 2007;101:1864–73.

    Article  PubMed  Google Scholar 

  61. Fedson DS. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly. Clin Geriatr Med. 1992;8:183–99.

    Article  CAS  PubMed  Google Scholar 

  62. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 1997;278:1333–9.

    Article  CAS  PubMed  Google Scholar 

  63. Rubins JB, Alter M, Loch J, Janoff EN. Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect Immun. 1999;67:5979–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Kolibab K, Smithson SL, Shriner AK, et al. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity. Immun Ageing. 2005;2:10.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. Lamontagne F, Garant MP, Carvalho JC, Lanthier L, Smieja M, Pilon D. Pneumococcal vaccination and risk of myocardial infarction. CMAJ. 2008;179:773–7.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372:1114–25.

    Article  CAS  PubMed  Google Scholar 

  67. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Schmader K. Herpes zoster in older adults. Clin Infect Dis. 2001;32:1481–6. Epub 2001 Apr 17.

    Google Scholar 

  69. Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127:305–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Oxman MN, Levin MJ. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197(Suppl 2):S228–36.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Drolet M, Brisson M, Schmader KE, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731–6.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Cunningham AL, Dworkin RH. The management of post-herpetic neuralgia. BMJ. 2000;321:778–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26–33.

    Article  PubMed  Google Scholar 

  74. Arvin AM, Moffat JF, Redman R. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv Virus Res. 1996;46:263–309.

    Article  CAS  PubMed  Google Scholar 

  75. Baiker A, Fabel K, Cozzio A, et al. Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci U S A. 2004;101:10792–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Vukmanovic-Stejic M, Sandhu D, Sobande TO, et al. Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans. J Immunol. 2013;190:977–86.

    Article  CAS  PubMed  Google Scholar 

  77. Vukmanovic-Stejic M, Sandhu D, Seidel JA, et al. The characterization of varicella zoster virus-specific T cells in skin and blood during aging. J Invest Dermatol. 2015;135:1752–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Arvin AM. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis. 2008;197(Suppl 2):S58–60.

    Article  CAS  PubMed  Google Scholar 

  79. Steain M, Sutherland JP, Rodriguez M, Cunningham AL, Slobedman B, Abendroth A. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia. J Virol. 2014;88:2704–16.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Gowrishankar K, Steain M, Cunningham AL, et al. Characterization of the host immune response in human Ganglia after herpes zoster. J Virol. 2010;84:8861–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–84.

    Article  CAS  PubMed  Google Scholar 

  82. Sei JJ, Cox KS, Dubey SA, et al. Effector and central memory poly-functional CD4(+) and CD8(+) T cells are boosted upon ZOSTAVAX((R)) vaccination. Front Immunol. 2015;6:553.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Cunningham AL, Heineman TC, Lal H, et al. Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged >/=50 years. J Infect Dis. 2018;217:1750.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Didierlaurent AM, Collignon C, Bourguignon P, et al. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells. J Immunol. 2014;193:1920–30.

    Article  CAS  PubMed  Google Scholar 

  85. Cunningham AL. The herpes zoster subunit vaccine. Expert Opin Biol Ther. 2016;16:265–71.

    Article  CAS  PubMed  Google Scholar 

  86. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372:2087–96.

    Article  PubMed  Google Scholar 

  87. Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019–32.

    Article  CAS  PubMed  Google Scholar 

  88. Evans CT, Johnson S. Prevention of Clostridium difficile infection with probiotics. Clin Infect Dis. 2015;60(Suppl 2):S122–8.

    Article  PubMed  Google Scholar 

  89. Shen NT, Maw A, Tmanova LL, et al. Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis. Gastroenterology. 2017;152:1889–900 e9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Sciences North Research Institute, Sudbury, ON, Canada

    Janet E. McElhaney

  2. Northern Ontario School of Medicine, Sudbury, ON, Canada

    Janet E. McElhaney

  3. Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada

    Melissa K. Andrew & Shelly McNeil

  4. Center on Aging, University of Connecticut School of Medicine, Farmington, CT, USA

    George A. Kuchel

Authors
  1. Janet E. McElhaney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melissa K. Andrew
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shelly McNeil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George A. Kuchel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janet E. McElhaney .

Editor information

Editors and Affiliations

  1. Center on Aging and Departments of Family Medicine and Medicine, University of Connecticut School of Medicine, Farmington, CT, USA

    Patrick P. Coll

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McElhaney, J.E., Andrew, M.K., McNeil, S., Kuchel, G.A. (2019). Preventing Infections and Healthy Aging. In: Coll, P. (eds) Healthy Aging. Springer, Cham. https://doi.org/10.1007/978-3-030-06200-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-06200-2_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-06199-9

  • Online ISBN: 978-3-030-06200-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation